Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04972942
Title Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma (ALLO-T-DART)
Acronym ALLO-T-DART
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors New York Medical College
Indications
Therapies
Age Groups: adult | child
Covered Countries USA


No variant requirements are available.